Information Journal Paper
APA:
Copy. (2018). Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial. LANCET NEUROLOGY, 17(8), 689-698. SID. https://sid.ir/paper/672431/en
Vancouver:
Copy. Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial. LANCET NEUROLOGY[Internet]. 2018;17(8):689-698. Available from: https://sid.ir/paper/672431/en
IEEE:
Copy, “Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial,” LANCET NEUROLOGY, vol. 17, no. 8, pp. 689–698, 2018, [Online]. Available: https://sid.ir/paper/672431/en